PT - JOURNAL ARTICLE AU - Ezra Aydin AU - Staci M. Weiss AU - Kevin A. Glasgow AU - Jane Barlow AU - Topun Austin AU - Mark H. Johnson AU - Sarah Lloyd-Fox TI - The COVID in the Context of Pregnancy, Infancy and Parenting (CoCoPIP) Study: protocol for a longitudinal study of parental mental health, social interactions, physical growth, and cognitive development of infants during the pandemic AID - 10.1101/2021.05.22.21257649 DP - 2021 Jan 01 TA - medRxiv PG - 2021.05.22.21257649 4099 - http://medrxiv.org/content/early/2021/05/24/2021.05.22.21257649.short 4100 - http://medrxiv.org/content/early/2021/05/24/2021.05.22.21257649.full AB - Introduction While the secondary impact of the COVID pandemic on the psychological wellbeing of pregnant women and parents has become apparent over the past year, the impact of these changes on early social interactions, physical growth and cognitive development of their infants is unknown, as is the way in which a range of COVID related changes have mediated this impact. This study (CoCoPIP) will investigate: i) how parent’s experiences of the social, medical, and financial changes during the pandemic have impacted pre and postnatal parental mental health and parent-infant social interaction; and (ii) the extent to which these COVID-related changes in parental pre and postnatal mental health and social interaction are associated with fetal and infant development.Methods and analysis The CoCoPIP study is a national online survey initiated in July 2020. This ongoing study (n = 1700 families currently enrolled as of 6th May 2021) involves both quantitative and qualitative data being collected across pregnancy and infancy. It is designed to identify the longitudinal impact of the pandemic from pregnancy to two years of age, with the aim of identifying if stress-associated moderators (i.e., loss of income, COVID-19 illness, access to ante/postnatal support) impact parental mental health, and in turn, infant development. In addition, we aim to document individual differences in social and cognitive development in toddlers who were born during restrictions intended to mitigate COVID-19 spread (e.g., social distancing, national lockdowns).Ethics and dissemination Ethical approval was given by the University of Cambridge, Psychology Research Ethics Committee (PREC) (PRE.2020.077). Findings will be made available via community engagement, public forums (e.g., social media,) and to national (e.g., NHS England) and local (Cambridge Universities Hospitals NHS Foundation Trust) healthcare partners. Results will be submitted for publication in peer-reviews journals.Strengths and Limitations of this study‐ This is a new cohort of families being followed from prenatal to postnatal (up to 18 months) during the COVID-19 pandemic.‐ The study involves the collection of quantifiable data to identify the short- and long-term influences of the pandemic on key aspects of infant development.‐ The study also has a range of open-ended questions for qualitative analysis aimed at exploring familial experiences in more detail.‐ The data is being collected online and is therefore limited to self- and parent-report measures, with no direct assessment of child development and parental mental health.‐ Although the sample of families being recruited are diverse in their indices of multiple deprivation (IMD) and geographic location, they may not be fully representative of the wider population.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research was funded by a Medical Research Council Programme Grant MR/T003057/1 to MJ, and an UKRI Future Leaders fellowship (MRC grant MR/S018425/1) to SLF. The views expressed are those of the authors and not necessarily those of the MRC or the UKRI. The NIHR Cambridge Biomedical Research Centre (BRC) is a partnership between Cambridge University Hospitals NHS Foundation Trust and the University of Cambridge, funded by the National Institute for Health Research (NIHR), T.A. is supported by the NIHR Cambridge Biomedical Research Centre (BRC). TA is also supported by the NIHR Brain Injury MedTech Co-operative. The views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical approval was given by the University of Cambridge, Psychology Research Ethics Committee (PREC) (PRE.2020.077).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesQuestionnaires and study goals were made available upon request using the Open Science Foundation platform in July 2020 and made public at https://osf.io/m7zuw/ in August 2020. Qualitative data generated and analysed during the study will not be made publicly available due to ethical and privacy restrictions, however researchers can submit a research proposal to the Data Sharing Management Committee to request access and collaboration. We will either make our datafile associated with each publication available on an opensource platform, following peer review and publication or 12 months after the completion of a follow-up timepoint. https://osf.io/m7zuw/